LGALS3 and Hypertension: In a study of 107 patients with hypertension, serum Gal3 was associated with increased odds of left ventricular remodeling before and after adjusting for body mass index (BMI) and systolic blood pressure (SBP) (OR: 14.76; 95% CI, 5.39–27.76, p < 0.001) (Yao et al., 2016).